United States · FDA National Drug Code directory
Toviaz
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0242_ca2031f1-5425-4d31-bf14-c865ec4e89b7
- Product NDC
- 0069-0242
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- fesoterodine fumarate
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20081031
- Source listing expiry
- 20271231
Source-listed ingredients
- FESOTERODINE FUMARATE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0242-30) · 0069-0242-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →